Merck & Co. Inc.’s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer ...

Alzheimer's disease—the most common form of dementia—is a progressive neurological disorder that causes brain cells to ...

A new study showed that methylated tirilazad treatment resulted in "significant improvement in clinical signs, blood markers, ...

"By repurposing existing drugs, we aim to bypass some of the lengthy and expensive steps in traditional antibiotic discovery, ...

The new ulcerative colitis (UC) triumvirate in Johnson & Johnson’s Tremfya, AbbVie’s Skyrizi and Eli Lilly’s Omvoh is rapidly ...

A year ago, there was 1 drug for idiopathic pulmonary fibrosis in trials at Temple Health. Now there are 10 active trials and 8 more coming up.

Patients with cancer could be willing to wait for greater certainty of the benefit of new cancer drugs before they are ...

TennCare – the state Medicaid program that pays the medical bills of 1.4 million low-income Tennesseans – is seeking a $975 ...

OCON Therapeutics invented a novel technology that allows for intrauterine drug delivery that could affect the wellbeing of ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...